Till, J. E., & Mc, C. E. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res, 14, 213–222.
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature, 385, 810–813.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147.
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent.". Nobel Media AB 2019, 2019. (Accessed January 21, 2019,
Sousa, B. R., Parreira, R. C., Fonseca, E. A., et al. (2014). Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry A, 85, 43–77.
Codega, P., Silva-Vargas, V., Paul, A., et al. (2014). Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche. Neuron, 82, 545–559.
Bond, A. M., Ming, G. L., & Song, H. (2015). Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later. Cell Stem Cell, 17, 385–395.
Liu Z, Cai Y, Wang Y, et al. Cloning of Macaque Monkeys by Somatic Cell Nuclear Transfer. Cell 2018;172:881-7.e7.
Dakhore, S., Nayer, B., & Hasegawa, K. (2018). Human Pluripotent Stem Cell Culture: Current Status, Challenges, and Advancement. Stem Cells Int, 2018, 7396905.
Kwon, S. G., Kwon, Y. W., Lee, T. W., Park, G. T., & Kim, J. H. (2018). Recent advances in stem cell therapeutics and tissue engineering strategies. Biomater Res, 22, 36.
Pizzicannella, J., Diomede, F., Merciaro, I., et al. (2018). Endothelial committed oral stem cells as modelling in the relationship between periodontal and cardiovascular disease. J Cell Physiol, 233, 6734–6747.
Spitalieri, P., Talarico, R. V., Caioli, S., et al. (2018). Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes. J Mol Cell Cardiol, 118, 95–109.
Savoji, H., Mohammadi, M. H., Rafatian, N., et al. (2018). Cardiovascular disease models: A game changing paradigm in drug discovery and screening. Biomaterials.
Cota-Coronado, A., Ramirez-Rodriguez, P. B., Padilla-Camberos, E., et al. (2018). Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine. Drug Discov Today.
Fantuzzo, J. A., Hart, R. P., Zahn, J. D., & Pang, Z. P. (2019). Compartmentalized Devices as Tools for Investigation of Human Brain Network Dynamics. Dev Dyn, 248, 65–77.
Nikolic, M. Z., Sun, D., & Rawlins, E. L. (2018). Human lung development: recent progress and new challenges. Development, 145.
Wobus, A. M., & Boheler, K. R. (2005). Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev, 85, 635–678.
Aoi, T. (2016). 10th anniversary of iPS cells: the challenges that lie ahead. J Biochem, 160, 121–129.
Ratajczak, M. Z., Ratajczak, J., & Kucia, M. (2019). Very Small Embryonic-Like Stem Cells (VSELs). Circ Res, 124, 208–210.
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006). The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia, 20, 1915–1924.
Kucia, M., Halasa, M., Wysoczynski, M., et al. (2007). Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia, 21, 297–303.
Suszynska, M., Zuba-Surma, E. K., Maj, M., et al. (2014). The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues. Stem Cells Dev, 23, 702–713.
Bhartiya, D., Shaikh, A., Anand, S., et al. (2016). Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead. Hum Reprod Update, 23, 41–76.
Miyanishi, M., Mori, Y., Seita, J., et al. (2013). Do pluripotent stem cells exist in adult mice as very small embryonic stem cells? Stem Cell Reports, 1, 198–208.
Ratajczak, M. Z., Ratajczak, J., Suszynska, M., Miller, D. M., Kucia, M., & Shin, D. M. (2017). A Novel View of the Adult Stem Cell Compartment From the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells. Circ Res, 120, 166–178.
Shin, D. M., Liu, R., Wu, W., et al. (2012). Global gene expression analysis of very small embryonic-like stem cells reveals that the Ezh2-dependent bivalent domain mechanism contributes to their pluripotent state. Stem Cells Dev, 21, 1639–1652.
Campbell, K. H., McWhir, J., Ritchie, W. A., & Wilmut, I. (1996). Sheep cloned by nuclear transfer from a cultured cell line. Nature, 380, 64–66.
Garcia-Sancho, M. (2015). Animal breeding in the age of biotechnology: the investigative pathway behind the cloning of Dolly the sheep. Hist Philos Life Sci, 37, 282–304.
Callaway E. Dolly at 20: The inside story on the world's most famous sheep. Nature. England2016:604-608.
Cyranoski D. First monkeys cloned with technique that made Dolly the sheep. Nature. England2018:387-388.
Singh, V. K., Kumar, N., Kalsan, M., Saini, A., & Chandra, R. (2015). Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs). J Stem Cells, 10, 43–62.
Felfly, H., & Haddad, G. G. (2014). Hematopoietic stem cells: potential new applications for translational medicine. J Stem Cells, 9, 163–197.
Park, B., Yoo, K. H., & Kim, C. (2015). Hematopoietic stem cell expansion and generation: the ways to make a breakthrough. Blood Res, 50, 194–203.
Schosserer, M., Reynoso, R., Wally, V., et al. (2015). Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa. BMC Res Notes, 8, 767.
Zhou, T., Benda, C., Dunzinger, S., et al. (2012). Generation of human induced pluripotent stem cells from urine samples. Nat Protoc, 7, 2080–2089.
Sun, H., Zhang, F., Wang, Y., et al. (2018). Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human. Stem Cell Res, 29, 28–31.
Zhang, Y., McNeill, E., Tian, H., et al. (2008). Urine derived cells are a potential source for urological tissue reconstruction. J Urol, 180, 2226–2233.
Bharadwaj, S., Liu, G., Shi, Y., et al. (2011). Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A, 17, 2123–2132.
Xue, Y., Cai, X., Wang, L., et al. (2013). Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS One, 8, e70573.
Jiang, Y. F., Chen, M., Zhang, N. N., Yang, H. J., Rui, Q., & Zhou, Y. F. (2018). In vitro and in vivo differentiation of induced pluripotent stem cells generated from urine-derived cells into cardiomyocytes. Biol Open, 7.
Zhang, X., Li, S., Yang, W., et al. (2016). Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization. Methods Mol Biol, 1353, 323–342.
Chen, C. Y., Rao, S. S., Ren, L., et al. (2018). Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics, 8, 1607–1623.
Guo, D., Wu, F., Liu, H., et al. (2017). Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome. Stem Cell Res, 18, 70–72.
Guo, D., Wu, F., Liu, H., et al. (2017). Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome. Stem Cell Res, 18, 64–66.
Sochacki, J., Devalle, S., Reis, M., Fontenelle, L. F., & Rehen, S. (2016). Generation of urine iPS cell line from a patient with obsessive-compulsive disorder using a non-integrative method. Stem Cell Res, 17, 107–110.
Wang, L., Huang, W., Su, H., et al. (2013). Generation of integration-free neural progenitor cells from cells in human urine. Nat Methods, 10, 84–89.
Liu, Y., Zheng, Y., Li, S., et al. (2017). Human neural progenitors derived from integration-free iPSCs for SCI therapy. Stem Cell Res, 19, 55–64.
Yi, H., Xie, B., Liu, B., et al. (2018). Derivation and Identification of Motor Neurons from Human Urine-Derived Induced Pluripotent Stem Cells. Stem Cells Int, 2018, 3628578.
Trawczynski, M., Liu, G., David, B. T., & Fessler, R. G. (2019). Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells. Front Cell Neurosci, 13, 369.
Wang, Y., Shi, C., Wang, Z., et al. (2018). Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3. Stem Cell Res, 28, 71–74.
Zhou, M., Hu, Z., Qiu, L., et al. (2018). Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells. Hum Gene Ther, 29, 1252–1263.
Rezza, A., Sennett, R., & Rendl, M. (2014). Adult stem cell niches: cellular and molecular components. Curr Top Dev Biol, 107, 333–372.
Ciubotariu, R., Scaradavou, A., Ciubotariu, I., et al. (2018). Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors? Transfusion, 58, 1427–1433.
Narayanan, D. L., & Phadke, S. R. (2019). Concepts, Utility and Limitations of Cord Blood Banking: What Clinicians Need to Know. Indian J Pediatr, 86, 44–48.
Shearer, W. T., Lubin, B. H., Cairo, M. S., & Notarangelo, L. D. (2017). Cord Blood Banking for Potential Future Transplantation. Pediatrics, 140.
Bhandari, R., Lindley, A., Bhatla, D., et al. (2017). Awareness of cord blood collection and the impact on banking. Pediatr Blood Cancer, 64.
Mimeault, M., & Batra, S. K. (2012). Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies. Adv Exp Med Biol, 741, 171–186.
Niu, W., Zang, T., Zou, Y., et al. (2013). In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol, 15, 1164–1175.
Srivastava, D., & DeWitt, N. (2016). In Vivo Cellular Reprogramming: The Next Generation. Cell, 166, 1386–1396.
Liang, J., Wan, M., Zhang, Y., et al. (2008). Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol, 10, 731–739.
Song, G., Pacher, M., Balakrishnan, A., et al. (2016). Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis. Cell Stem Cell, 18, 797–808.
Song, K., Nam, Y. J., Luo, X., et al. (2012). Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature, 485, 599–604.
Qian, L., Huang, Y., Spencer, C. I., et al. (2012). In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature, 485, 593–598.
Torper, O., Pfisterer, U., Wolf, D. A., et al. (2013). Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A, 110, 7038–7043.
Liu, Y., Miao, Q., Yuan, J., et al. (2015). Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo. J Neurosci, 35, 9336–9355.
Ueki, Y., Wilken, M. S., Cox, K. E., et al. (2015). Transgenic expression of the proneural transcription factor Ascl1 in Muller glia stimulates retinal regeneration in young mice. Proc Natl Acad Sci U S A, 112, 13717–13722.
Karow, M., Sanchez, R., Schichor, C., et al. (2012). Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell, 11, 471–476.
Hu, B. Y., Weick, J. P., Yu, J., et al. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A, 107, 4335–4340.
Bhutani, N., Brady, J. J., Damian, M., Sacco, A., Corbel, S. Y., & Blau, H. M. (2010). Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature, 463, 1042–1047.
Sullivan, G. J., Bai, Y., Fletcher, J., & Wilmut, I. (2010). Induced pluripotent stem cells: epigenetic memories and practical implications. Mol Hum Reprod, 16, 880–885.
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Sudhof, T. C., & Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463, 1035–1041.
Lowry, W. E., Richter, L., Yachechko, R., et al. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A, 105, 2883–2888.
Park, I. H., Zhao, R., West, J. A., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141–146.
Kilens, S., Meistermann, D., Moreno, D., et al. (2018). Parallel derivation of isogenic human primed and naive induced pluripotent stem cells. Nat Commun, 9, 360.
Chan, Y. S., Goke, J., Ng, J. H., et al. (2013). Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell, 13, 663–675.
Gafni, O., Weinberger, L., Mansour, A. A., et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature, 504, 282–286.
Ware, C. B., Nelson, A. M., Mecham, B., et al. (2014). Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A, 111, 4484–4489.
Wang, J., Rao, S., Chu, J., et al. (2006). A protein interaction network for pluripotency of embryonic stem cells. Nature, 444, 364–368.
Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
Feng, B., Ng, J. H., Heng, J. C., & Ng, H. H. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 4, 301–312.
Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell. United States2008:10-2.
Huangfu, D., Osafune, K., Maehr, R., et al. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol, 26, 1269–1275.
Kim, J. B., Zaehres, H., Wu, G., et al. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature, 454, 646–650.
Kim, J. B., Greber, B., Arauzo-Bravo, M. J., et al. (2009). Direct reprogramming of human neural stem cells by OCT4. Nature, 461, 649–643.
Kim, J. B., Sebastiano, V., Wu, G., et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell, 136, 411–419.
Tsai, S. Y., Bouwman, B. A., Ang, Y. S., et al. (2011). Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells, 29, 964–971.
Hanna, J., Markoulaki, S., Schorderet, P., et al. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell, 133, 250–264.
Maherali, N., & Hochedlinger, K. (2008). Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 3, 595–605.
Mikkelsen, T. S., Hanna, J., Zhang, X., et al. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature, 454, 49–55.
Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458, 771–775.
Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-770.
Wang, W., Bradley, A., & Huang, Y. (2009). A piggyBac transposon-based genome-wide library of insertionally mutated Blm-deficient murine ES cells. Genome Res, 19, 667–673.
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949–953.
Schlaeger, T. M., Daheron, L., Brickler, T. R., et al. (2015). A comparison of non-integrating reprogramming methods. Nat Biotechnol, 33, 58–63.
Fusaki, N., Ban, H., Nishiyama, A., Saeki, K., & Hasegawa, M. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci, 85, 348–362.
Okita, K., Matsumura, Y., Sato, Y., et al. (2011). A more efficient method to generate integration-free human iPS cells. Nat Methods, 8, 409–412.
Yu, J., Hu, K., Smuga-Otto, K., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797–801.
Warren, L., Manos, P. D., Ahfeldt, T., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618–630.
Park, T. S., Huo, J. S., Peters, A., et al. (2012). Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors. PLoS One, 7, e42838.
Yu, J., Chau, K. F., Vodyanik, M. A., Jiang, J., & Jiang, Y. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS One, 6, e17557.
Su, R. J. (2013). Baylink DJ, Neises A, et al. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One, 8, e64496.
Wang, Y., Chen, J., Hu, J. L., et al. (2011). Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep, 12, 373–378.
Surget, S., Khoury, M. P., & Bourdon, J. C. (2013). Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther, 7, 57–68.
Maimets, T., Neganova, I., Armstrong, L., & Lako, M. (2008). Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene, 27, 5277–5287.
Jain, A. K., Allton, K., Iacovino, M., et al. (2012). p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol, 10, e1001268.
Zhao Y, Yin X, Qin H, et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell. United States2008:475-479.
Nishimoto, M., Fukushima, A., Okuda, A., & Muramatsu, M. (1999). The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol, 19, 5453–5465.
Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell, 2, 230–240.
Hou, P., Li, Y., Zhang, X., et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science, 341, 651–654.
Zhao, Y., Zhao, T., Guan, J., et al. (2015). A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming. Cell, 163, 1678–1691.
Ma, X., Kong, L., & Zhu, S. (2017). Reprogramming cell fates by small molecules. Protein Cell, 8, 328–348.
Nishi, M., Akutsu, H., Masui, S., et al. (2011). A distinct role for Pin1 in the induction and maintenance of pluripotency. J Biol Chem, 286, 11593–11603.
Yusa, K., Rad, R., Takeda, J., & Bradley, A. (2009). Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods, 6, 363–369.
Wesselschmidt, R. L. (2011). The teratoma assay: an in vivo assessment of pluripotency. Methods Mol Biol, 767, 231–241.
Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313–317.
Marson A, Foreman R, Chevalier B, et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell. United States2008:132-135.
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med, 10, 55–63.
Chen, J., Nefzger, C. M., Rossello, F. J., et al. (2018). Fine Tuning of Canonical Wnt Stimulation Enhances Differentiation of Pluripotent Stem Cells Independent of beta-Catenin-Mediated T-Cell Factor Signaling. Stem Cells, 36, 822–833.
Cole, M. F., Johnstone, S. E., Newman, J. J., Kagey, M. H., & Young, R. A. (2008). Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev, 22, 746–755.
De Angelis, M. T., Parrotta, E. I., Santamaria, G., & Cuda, G. (2018). Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells. Cell Death Dis, 9, 6.
Osakada, F., & Takahashi, M. (2011). Neural induction and patterning in Mammalian pluripotent stem cells. CNS Neurol Disord Drug Targets, 10, 419–432.
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol, 6, e253.
Niwa, H., Burdon, T., Chambers, I., & Smith, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev, 12, 2048–2060.
Yu, J., & Thomson, J. A. (2008). Pluripotent stem cell lines. Genes Dev, 22, 1987–1997.
Li W, Wei W, Zhu S, et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell. United States2009:16-19.
Ma, X., Chen, H., & Chen, L. (2016). A dual role of Erk signaling in embryonic stem cells. Exp Hematol, 44, 151–156.
Burdon, T., Stracey, C., Chambers, I., Nichols, J., & Smith, A. (1999). Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol, 210, 30–43.
Kunath, T., Saba-El-Leil, M. K., Almousailleakh, M., Wray, J., Meloche, S., & Smith, A. (2007). FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development, 134, 2895–2902.
Ying, Q. L., Wray, J., Nichols, J., et al. (2008). The ground state of embryonic stem cell self-renewal. Nature, 453, 519–523.
Dvorak, P., Dvorakova, D., Koskova, S., et al. (2005). Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Stem Cells, 23, 1200–1211.
Page, R. L., Ambady, S., Holmes, W. F., et al. (2009). Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells, 11, 417–426.
Huangfu, D., Maehr, R., Guo, W., et al. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol, 26, 795–797.
Kang, S. J., Park, Y. I., So, B., & Kang, H. G. (2014). Sodium butyrate efficiently converts fully reprogrammed induced pluripotent stem cells from mouse partially reprogrammed cells. Cell Reprogram, 16, 345–354.
Esteban, M. A., Wang, T., Qin, B., et al. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 6, 71–79.
Cheng, L., Lei, Q., Yin, C., Wang, H. Y., Jin, K., & Xiang, M. (2017). Generation of Urine Cell-Derived Non-integrative Human iPSCs and iNSCs: A Step-by-Step Optimized Protocol. Front Mol Neurosci, 10, 348.
Ye, J., & Blelloch, R. (2014). Regulation of pluripotency by RNA binding proteins. Cell Stem Cell, 15, 271–280.
Ivey, K. N., Muth, A., Arnold, J., et al. (2008). MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2, 219–229.
Pastor, W. A., Chen, D., Liu, W., et al. (2016). Naive Human Pluripotent Cells Feature a Methylation Landscape Devoid of Blastocyst or Germline Memory. Cell Stem Cell, 18, 323–329.
Theunissen, T. W., Powell, B. E., Wang, H., et al. (2014). Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell, 15, 471–487.
Yang, Y., Zhang, X., Yi, L., et al. (2016). Naive Induced Pluripotent Stem Cells Generated From beta-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9. Stem Cells Transl Med, 5, 8–19.
Wang, Y., Zhao, C., Hou, Z., et al. (2018). Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naive state. Elife, 7.
Neff, A. T., Lee, J. Y., Wilusz, J., Tian, B., & Wilusz, C. J. (2012). Global analysis reveals multiple pathways for unique regulation of mRNA decay in induced pluripotent stem cells. Genome Res, 22, 1457–1467.
Wang, Y., Sun, T., Wang, K., Wang, J. X., & Li, P. F. (2014). PiRNAs link epigenetic modifications to reprogramming. Histol Histopathol, 29, 1489–1497.
Lin, S. L., Chang, D. C., Chang-Lin, S., et al. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. Rna, 14, 2115–2124.
Newman, M. A., Thomson, J. M., & Hammond, S. M. (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. Rna, 14, 1539–1549.
Viswanathan, S. R., Daley, G. Q., & Gregory, R. I. (2008). Selective blockade of microRNA processing by Lin28. Science, 320, 97–100.
Huang, M. L., Michalak, A. L., Fisher, C. J., Christy, M., Smith, R. A. A., & Godula, K. (2018). Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells, 36, 45–54.
Li, D., Wang, L., Hou, J., et al. (2016). Optimized Approaches for Generation of Integration-free iPSCs from Human Urine-Derived Cells with Small Molecules and Autologous Feeder. Stem Cell Reports, 6, 717–728.
Lin, T., Ambasudhan, R., Yuan, X., et al. (2009). A chemical platform for improved induction of human iPSCs. Nat Methods, 6, 805–808.
Zhu S, Li W, Zhou H, et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell. United States2010:651-655.
Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. United States2008:525-528.
Hong, H., Takahashi, K., Ichisaka, T., et al. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460, 1132–1135.
Mali, P., Chou, B. K., Yen, J., et al. (2010). Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells, 28, 713–720.
Zhang, Z., & Wu, W. S. (2013). Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster. Stem Cells Dev, 22, 2268–2277.
Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Scholer, H. R., & Ding, S. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 3, 568–574.
Duncan, E. J., Gluckman, P. D., & Dearden, P. K. (2014). Epigenetics, plasticity, and evolution: How do we link epigenetic change to phenotype? J Exp Zool B Mol Dev Evol, 322, 208–220.
Keller, A., & Dziedzicka, D. (2018). Zambelli F, et al. Hum Reprod Update: Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells.
Liang, G., & Zhang, Y. (2013). Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell, 13, 149–159.
Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285–290.
Kim, K., Zhao, R., Doi, A., et al. (2011). Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol, 29, 1117–1119.
Carey, B. W., Markoulaki, S., Hanna, J. H., et al. (2011). Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell, 9, 588–598.
Liu, L. (2017). Linking Telomere Regulation to Stem Cell Pluripotency. Trends Genet, 33, 16–33.
Rivera, T., Haggblom, C., Cosconati, S., & Karlseder, J. (2017). A balance between elongation and trimming regulates telomere stability in stem cells. Nat Struct Mol Biol, 24, 30–39.
Zhao, Z., Pan, X., Liu, L., & Liu, N. (2014). Telomere length maintenance, shortening, and lengthening. J Cell Physiol, 229, 1323–1329.
De Bonis, M. L., Ortega, S., & Blasco, M. A. (2014). SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells. Stem Cell Reports, 2, 690–706.
Kinoshita, T., Nagamatsu, G., Saito, S., Takubo, K., Horimoto, K., & Suda, T. (2014). Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming. J Biol Chem, 289, 15776–15787.
Armstrong, L., Tilgner, K., Saretzki, G., et al. (2010). Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells, 28, 661–673.
Nagaria, P. K., Robert, C., Park, T. S., Huo, J. S., Zambidis, E. T., & Rassool, F. V. (2016). High-Fidelity Reprogrammed Human IPSCs Have a High Efficacy of DNA Repair and Resemble hESCs in Their MYC Transcriptional Signature. Stem Cells Int, 2016, 3826249.
Neganova, I., Tilgner, K., Buskin, A., et al. (2014). CDK1 plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells. Cell Death Dis, 5, e1508.
von Joest, M., Bua Aguin, S., & Li, H. (2016). Genomic stability during cellular reprogramming: Mission impossible? Mutat Res, 788, 12–16.
Ruiz, S., Panopoulos, A. D., Herrerias, A., et al. (2011). A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol, 21, 45–52.
Mathieu, J., Zhou, W., Xing, Y., et al. (2014). Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. Cell Stem Cell, 14, 592–605.
Nagaria, P., Robert, C., & Rassool, F. V. (1830). DNA double-strand break response in stem cells: mechanisms to maintain genomic integrity. Biochim Biophys Acta, 2013, 2345–2353.
Dumitru, R., Gama, V., Fagan, B. M., et al. (2012). Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. Mol Cell, 46, 573–583.
Saretzki, G., Armstrong, L., Leake, A., Lako, M., & von Zglinicki, T. (2004). Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells, 22, 962–971.
Adams, B. R., Golding, S. E., Rao, R. R., & Valerie, K. (2010). Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS One, 5, e10001.
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017). Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Stem Cell Rev Rep, 13, 7–16.
Doss, M. X., & Sachinidis, A. (2019). Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells, 8.
Hockemeyer, D., & Jaenisch, R. (2016). Induced Pluripotent Stem Cells Meet Genome Editing. Cell Stem Cell, 18, 573–586.
Ferreccio, A., Mathieu, J., Detraux, D., et al. (2018). Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal. Cell Cycle, 17, 535–549.
Steyer, B., Cory, E., & Saha, K. (2018). Developing precision medicine using scarless genome editing of human pluripotent stem cells. Drug Discov Today Technol, 28, 3–12.
Steyer, B., Bu, Q., Cory, E., et al. (2018). Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection. Stem Cell Reports, 10, 642–654.
Jung, Y., Bauer, G., & Nolta, J. A. (2012). Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells, 30, 42–47.
Lambshead, J. W., Meagher, L., Goodwin, J., et al. (2018). Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces. Sci Rep, 8, 701.
Stover, A. E., & Schwartz, P. H. (2011). Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging. Methods Mol Biol, 767, 137–146.
Lai, W. H., Ho, J. C., Lee, Y. K., et al. (2010). ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system. Cell Reprogram, 12, 641–653.
Emonard, H., Grimaud, J. A., Nusgens, B., Lapiere, C. M., & Foidart, J. M. (1987). Reconstituted basement-membrane matrix modulates fibroblast activities in vitro. J Cell Physiol, 133, 95–102.
Bergstrom, R., Strom, S., Holm, F., Feki, A., & Hovatta, O. (2011). Xeno-free culture of human pluripotent stem cells. Methods Mol Biol, 767, 125–136.
Ausubel, L. J., Lopez, P. M., & Couture, L. A. (2011). GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol Biol, 767, 147–159.
Chen, G., Gulbranson, D. R., Hou, Z., et al. (2011). Chemically defined conditions for human iPSC derivation and culture. Nat Methods, 8, 424–429.
Miyazaki, T., Futaki, S., Suemori, H., et al. (2012). Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun, 3, 1236.
Rodin, S., Domogatskaya, A., Strom, S., et al. (2010). Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol, 28, 611–615.
Mei, Y., Saha, K., Bogatyrev, S. R., et al. (2010). Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater, 9, 768–778.
Lu, H. F., Narayanan, K., Lim, S. X., Gao, S., Leong, M. F., & Wan, A. C. (2012). A 3D microfibrous scaffold for long-term human pluripotent stem cell self-renewal under chemically defined conditions. Biomaterials, 33, 2419–2430.
Jung, S., Panchalingam, K. M., Rosenberg, L., & Behie, L. A. (2012). Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int, 2012, 123030.
Suga H. Recapitulating Hypothalamus and Pituitary Development Using Embryonic Stem/Induced Pluripotent Stem Cells. In: Pfaff D, Christen Y, eds. Stem Cells in Neuroendocrinology. Cham (CH): Springer Copyright 2016, The Author(s). 2016:35-50.
Nakashima, Y., & Omasa, T. (2016). What Kind of Signaling Maintains Pluripotency and Viability in Human-Induced Pluripotent Stem Cells Cultured on Laminin-511 with Serum-Free Medium? Biores Open Access, 5, 84–93.
Liu W, Chen G. Cryopreservation of human pluripotent stem cells in defined medium. Curr Protoc Stem Cell Biol 2014;31:1c.17.1-3.
de Soure, A. M., Fernandes-Platzgummer, A., da Silva, C. L., & Cabral, J. M. (2016). Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells. J Biotechnol, 236, 88–109.
Tan, K. Y., Reuveny, S., & Oh, S. K. (2016). Recent advances in serum-free microcarrier expansion of mesenchymal stromal cells: Parameters to be optimized. Biochem Biophys Res Commun, 473, 769–773.
Shih, D. T., & Burnouf, T. (2015). Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. N Biotechnol, 32, 199–211.
Burnouf, T., Strunk, D., Koh, M. B., & Schallmoser, K. (2016). Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials, 76, 371–387.
Ilic, D. (2006). Culture of human embryonic stem cells and the extracellular matrix microenvironment. Regen Med, 1, 95–101.
Mannello, F., & Tonti, G. A. (2007). Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells, 25, 1603–1609.
Marinho, P. A., Fernandes, A. M., Cruz, J. C., Rehen, S. K., & Castilho, L. R. (2010). Maintenance of pluripotency in mouse embryonic stem cells cultivated in stirred microcarrier cultures. Biotechnol Prog, 26, 548–555.
Fan, Y., Hsiung, M., Cheng, C., & Tzanakakis, E. S. (2014). Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A, 20, 588–599.
Williams, D. F. (2009). On the nature of biomaterials. Biomaterials, 30, 5897–5909.
Mohamed, F., & van der Walle, C. F. (2008). Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci, 97, 71–87.
Makadia, H. K., & Siegel, S. J. (2011). Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel), 3, 1377–1397.
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Preat, V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Release, 161, 505–522.
Ankrum, J. A., Miranda, O. R., Ng, K. S., Sarkar, D., Xu, C., & Karp, J. M. (2014). Engineering cells with intracellular agent-loaded microparticles to control cell phenotype. Nat Protoc, 9, 233–245.
Xu, C., Miranda-Nieves, D., Ankrum, J. A., et al. (2012). Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett, 12, 4131–4139.
Ankrum, J. A., Dastidar, R. G., Ong, J. F., Levy, O., & Karp, J. M. (2014). Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci Rep, 4, 4645.
Dellatore, S. M., Garcia, A. S., & Miller, W. M. (2008). Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol, 19, 534–540.
Scadden, D. T. (2006). The stem-cell niche as an entity of action. Nature, 441, 1075–1079.
Dingal, P. C., & Discher, D. E. (2014). Combining insoluble and soluble factors to steer stem cell fate. Nat Mater, 13, 532–537.
Lutolf, M. P., Gilbert, P. M., & Blau, H. M. (2009). Designing materials to direct stem-cell fate. Nature, 462, 433–441.
Murphy, S. V., & Atala, A. (2014). 3D bioprinting of tissues and organs. Nat Biotechnol, 32, 773–785.
Murphy, W. L., McDevitt, T. C., & Engler, A. J. (2014). Materials as stem cell regulators. Nat Mater, 13, 547–557.
Higuchi, A., Ling, Q. D., Ko, Y. A., Chang, Y., & Umezawa, A. (2011). Biomaterials for the feeder-free culture of human embryonic stem cells and induced pluripotent stem cells. Chem Rev, 111, 3021–3035.
de Peppo, G. M., Marcos-Campos, I., Kahler, D. J., et al. (2013). Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci U S A, 110, 8680–8685.
Teng, S., Liu, C., Krettek, C., & Jagodzinski, M. (2014). The application of induced pluripotent stem cells for bone regeneration: current progress and prospects. Tissue Eng Part B Rev, 20, 328–339.
Lei, Y., & Schaffer, D. V. (2013). A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci U S A, 110, E5039–E5048.
McKee, C., Perez-Cruet, M., Chavez, F., & Chaudhry, G. R. (2015). Simplified three-dimensional culture system for long-term expansion of embryonic stem cells. World J Stem Cells, 7, 1064–1077.
Saha, S., Ji, L., de Pablo, J. J., & Palecek, S. P. (2006). Inhibition of human embryonic stem cell differentiation by mechanical strain. J Cell Physiol, 206, 126–137.
Xu, Y., Zhu, X., Hahm, H. S., et al. (2010). Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A, 107, 8129–8134.
Cetinkaya, G., Turkoglu, H., Arat, S., et al. (2007). LIF-immobilized nonwoven polyester fabrics for cultivation of murine embryonic stem cells. J Biomed Mater Res A, 81, 911–919.
Alberti, K., Davey, R. E., Onishi, K., et al. (2008). Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods, 5, 645–650.
Miura, T., Sugawara, T., Fukuda, A., et al. (2015). Generation of primitive neural stem cells from human fibroblasts using a defined set of factors. Biol Open, 4, 1595–1607.
Saha, K., Mei, Y., Reisterer, C. M., et al. (2011). Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci U S A, 108, 18714–18719.
Adnan, N., Mie, M., Haque, A., et al. (2016). Construction of a Defined Biomimetic Matrix for Long-Term Maintenance of Mouse Induced Pluripotent Stem Cells. Bioconjug Chem, 27, 1599–1605.
Musah, S., Wrighton, P. J., Zaltsman, Y., et al. (2014). Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification. Proc Natl Acad Sci U S A, 111, 13805–13810.
Wang, A., Tang, Z., Park, I. H., et al. (2011). Induced pluripotent stem cells for neural tissue engineering. Biomaterials, 32, 5023–5032.
Kuo, Y. C., & Lin, C. C. (2013). Accelerated nerve regeneration using induced pluripotent stem cells in chitin-chitosan-gelatin scaffolds with inverted colloidal crystal geometry. Colloids Surf B Biointerfaces, 103, 595–600.
Pan, F., Zhang, M., Wu, G., et al. (2013). Topographic effect on human induced pluripotent stem cells differentiation towards neuronal lineage. Biomaterials, 34, 8131–8139.
Solanki, A., Shah, S., Memoli, K. A., Park, S. Y., Hong, S., & Lee, K. B. (2010). Controlling differentiation of neural stem cells using extracellular matrix protein patterns. Small, 6, 2509–2513.
Albalushi, H., Kurek, M., Karlsson, L., et al. (2018). Laminin 521 Stabilizes the Pluripotency Expression Pattern of Human Embryonic Stem Cells Initially Derived on Feeder Cells. Stem Cells Int, 2018, 7127042.
Terashima, M., Amano, M., Onodera, T., Nishimura, S., & Iwasaki, N. (2014). Quantitative glycomics monitoring of induced pluripotent- and embryonic stem cells during neuronal differentiation. Stem Cell Res, 13, 454–464.
Zhang, D., Pekkanen-Mattila, M., Shahsavani, M., Falk, A., Teixeira, A. I., & Herland, A. (2014). A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials, 35, 1420–1428.
Yang, K., Lee, J. S., Kim, J., et al. (2012). Polydopamine-mediated surface modification of scaffold materials for human neural stem cell engineering. Biomaterials, 33, 6952–6964.
Kuo, Y. C., & Wang, C. T. (2012). Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface. Colloids Surf B Biointerfaces, 100, 9–15.
Wang, Y., Cheng, L., & Gerecht, S. (2014). Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013. Ann Biomed Eng, 42, 1357–1372.
Zonca Jr., M. R., Yune, P. S., Heldt, C. L., Belfort, G., & Xie, Y. (2013). High-throughput screening of substrate chemistry for embryonic stem cell attachment, expansion, and maintaining pluripotency. Macromol Biosci, 13, 177–190.
Underhill GH, Khetani SR. Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies. Cell Mol Gastroenterol Hepatol 2018;5:426-39.e1.
Epa, V. C., Burden, F. R., Tassa, C., Weissleder, R., Shaw, S., & Winkler, D. A. (2012). Modeling biological activities of nanoparticles. Nano Lett, 12, 5808–5812.
Bratt-Leal, A. M., Nguyen, A. H., Hammersmith, K. A., Singh, A., & McDevitt, T. C. (2013). A microparticle approach to morphogen delivery within pluripotent stem cell aggregates. Biomaterials, 34, 7227–7235.
Kraehenbuehl, T. P., Langer, R., & Ferreira, L. S. (2011). Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods, 8, 731–736.
Sant S, Hancock MJ, Donnelly JP, Iyer D, Khademhosseini A. BIOMIMETIC GRADIENT HYDROGELS FOR TISSUE ENGINEERING. Can J Chem Eng 2010;88:899-911.
Han, Y. L., Wang, S., Zhang, X., et al. (2014). Engineering physical microenvironment for stem cell based regenerative medicine. Drug Discov Today, 19, 763–773.
McDevitt, T. C. (2013). Scalable culture of human pluripotent stem cells in 3D. Proc Natl Acad Sci U S A, 110, 20852–20853.
Chen, K. G., Mallon, B. S., McKay, R. D., & Robey, P. G. (2014). Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell, 14, 13–26.
Sasai, Y. (2013). Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell, 12, 520–530.
Guillotin, B., Souquet, A., Catros, S., et al. (2010). Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials, 31, 7250–7256.
Moon, S., Hasan, S. K., Song, Y. S., et al. (2010). Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng Part C Methods, 16, 157–166.
Xu, T., Zhao, W., Zhu, J. M., Albanna, M. Z., Yoo, J. J., & Atala, A. (2013). Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials, 34, 130–139.
Poldervaart, M. T., Gremmels, H., van Deventer, K., et al. (2014). Prolonged presence of VEGF promotes vascularization in 3D bioprinted scaffolds with defined architecture. J Control Release, 184, 58–66.
Levato, R., Visser, J., Planell, J. A., Engel, E., Malda, J., & Mateos-Timoneda, M. A. (2014). Biofabrication of tissue constructs by 3D bioprinting of cell-laden microcarriers. Biofabrication, 6, 035020.
Neufurth, M., Wang, X., Schroder, H. C., et al. (2014). Engineering a morphogenetically active hydrogel for bioprinting of bioartificial tissue derived from human osteoblast-like SaOS-2 cells. Biomaterials, 35, 8810–8819.
Tong, Z., Solanki, A., Hamilos, A., et al. (2015). Application of biomaterials to advance induced pluripotent stem cell research and therapy. Embo j, 34, 987–1008.
Park, J. Y., Choi, J. C., Shim, J. H., et al. (2014). A comparative study on collagen type I and hyaluronic acid dependent cell behavior for osteochondral tissue bioprinting. Biofabrication, 6, 035004.
Kolesky, D. B., Truby, R. L., Gladman, A. S., Busbee, T. A., Homan, K. A., & Lewis, J. A. (2014). 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater, 26, 3124–3130.
Kempermann, G., Gage, F. H., Aigner, L., et al. (2018). Human Adult Neurogenesis: Evidence and Remaining Questions. Cell Stem Cell, 23, 25–30.
Takahashi, J. (2018). Stem cells and regenerative medicine for neural repair. Curr Opin Biotechnol, 52, 102–108.
Gazdic, M., Volarevic, V., Harrell, C. R., et al. (2018). Stem Cells Therapy for Spinal Cord Injury. Int J Mol Sci, 19.
Weston, N. M., & Sun, D. (2018). The Potential of Stem Cells in Treatment of Traumatic Brain Injury. Curr Neurol Neurosci Rep, 18, 1.
Niimi, Y., & Levison, S. W. (2018). Pediatric brain repair from endogenous neural stem cells of the subventricular zone. Pediatr Res, 83, 385–396.
Cox Jr., C. S. (2018). Cellular therapy for traumatic neurological injury. Pediatr Res, 83, 325–332.
Kang, J. M., Yeon, B. K., Cho, S. J., & Suh, Y. H. (2016). Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials. J Alzheimers Dis, 54, 879–889.
Wang, Z., Peng, W., Zhang, C., et al. (2015). Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis. Sci Rep, 5, 12134.
Kriks, S., Shim, J. W., Piao, J., et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature, 480, 547–551.
Ciervo, Y., Ning, K., Jun, X., Shaw, P. J., & Mead, R. J. (2017). Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis. Mol Neurodegener, 12, 85.
Coelho, R., Hanna, R., Flagg, A., et al. (2017). Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature. Transpl Infect Dis, 19.
Xian, B., & Huang, B. (2015). The immune response of stem cells in subretinal transplantation. Stem Cell Res Ther, 6, 161.
Mauritz, C., Schwanke, K., Reppel, M., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118, 507–517.
Kuzmenkin, A., Liang, H., Xu, G., et al. (2009). Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. Faseb j, 23, 4168–4180.
Andersen, P. M., & Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol, 7, 603–615.
Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-1775.
Arnold, E. S., Ling, S. C., Huelga, S. C., et al. (2013). ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A, 110, E736–E745.
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218–1221.
Karumbayaram, S., Novitch, B. G., Patterson, M., et al. (2009). Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 27, 806–811.
Popescu, I. R., Nicaise, C., Liu, S., et al. (2013). Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis. Stem Cells Transl Med, 2, 167–174.
Nizzardo, M., Simone, C., Rizzo, F., et al. (2014). Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet, 23, 342–354.
Malide D, Metais JY, Dunbar CE. In vivo clonal tracking of hematopoietic stem and progenitor cells marked by five fluorescent proteins using confocal and multiphoton microscopy. J Vis Exp 2014:e51669.
Robberecht, W., & Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci, 14, 248–264.
Lund, R. D., Wang, S., Klimanskaya, I., et al. (2006). Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells, 8, 189–199.
Kawamura, M., Miyagawa, S., Miki, K., et al. (2012). Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation, 126, S29–S37.
Trounson, A., & McDonald, C. (2015). Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell, 17, 11–22.
Romito, A., & Cobellis, G. (2016). Pluripotent Stem Cells: Current Understanding and Future Directions. Stem Cells Int, 2016, 9451492.
Priest, C. A., Manley, N. C., Denham, J., Wirth 3rd, E. D., & Lebkowski, J. S. (2015). Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. Regen Med, 10, 939–958.
Manley, N. C., Priest, C. A., Denham, J., Wirth 3rd, E. D., & Lebkowski, J. S. (2017). Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury. Stem Cells Transl Med, 6, 1917–1929.
Mandai, M., Watanabe, A., Kurimoto, Y., et al. (2017). Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med, 376, 1038–1046.
Takagi, S., & Mandai, M. (2019). Gocho K, et al. Ophthalmol Retina: Evaluation of Transplanted Autologous Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in Exudative Age-Related Macular Degeneration.
Imaizumi, Y., & Okano, H. (2014). Modeling human neurological disorders with induced pluripotent stem cells. J Neurochem, 129, 388–399.
Devine, M. J., Ryten, M., Vodicka, P., et al. (2011). Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun, 2, 440.
Nguyen, H. N., Byers, B., Cord, B., et al. (2011). LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell, 8, 267–280.
Cooper O, Seo H, Andrabi S, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 2012;4:141ra90.
Desbordes, S. C., & Studer, L. (2013). Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat Protoc, 8, 111–130.
Telias, M., & Ben-Yosef, D. (2014). Modeling neurodevelopmental disorders using human pluripotent stem cells. Stem Cell Rev, 10, 494–511.
Ardhanareeswaran, K., Mariani, J., Coppola, G., Abyzov, A., & Vaccarino, F. M. (2017). Human induced pluripotent stem cells for modelling neurodevelopmental disorders. Nat Rev Neurol, 13, 265–278.
Compagnucci, C., Nizzardo, M., Corti, S., Zanni, G., & Bertini, E. (2014). In vitro neurogenesis: development and functional implications of iPSC technology. Cell Mol Life Sci, 71, 1623–1639.
O'Shea, K. S., & McInnis, M. G. (2016). Neurodevelopmental origins of bipolar disorder: iPSC models. Mol Cell Neurosci, 73, 63–83.
Kelava, I., & Lancaster, M. A. (2016). Dishing out mini-brains: Current progress and future prospects in brain organoid research. Dev Biol, 420, 199–209.
Li, L. B., & Bonini, N. M. (2010). Roles of trinucleotide-repeat RNA in neurological disease and degeneration. Trends Neurosci, 33, 292–298.
Rami, F., Beni, S. N., Kahnamooi, M. M., Rahimmanesh, I., Salehi, A. R., & Salehi, R. (2017). Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells. Cell Reprogram, 19, 65–74.
Ader, M., & Tanaka, E. M. (2014). Modeling human development in 3D culture. Curr Opin Cell Biol, 31, 23–28.
Salmasi, S., Kalaskar, D. M., Yoon, W. W., Blunn, G. W., & Seifalian, A. M. (2015). Role of nanotopography in the development of tissue engineered 3D organs and tissues using mesenchymal stem cells. World J Stem Cells, 7, 266–280.
Stabler, C. T., Lecht, S., Mondrinos, M. J., Goulart, E., Lazarovici, P., & Lelkes, P. I. (2015). Revascularization of decellularized lung scaffolds: principles and progress. Am J Physiol Lung Cell Mol Physiol, 309, L1273–L1285.
Babczyk, P., Conzendorf, C., Klose, J., Schulze, M., Harre, K., & Tobiasch, E. (2014). Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing. J Clin Med, 3, 39–87.
Baptista, L. S., Kronemberger, G. S., Cortes, I., et al. (2018). Adult Stem Cells Spheroids to Optimize Cell Colonization in Scaffolds for Cartilage and Bone Tissue Engineering. Int J Mol Sci, 19.
Huang, Y., Zhang, X. F., Gao, G., Yonezawa, T., & Cui, X. (2017). 3D bioprinting and the current applications in tissue engineering. Biotechnol J, 12.
Hussey, G. S., Cramer, M. C., & Badylak, S. F. (2018). Extracellular Matrix Bioscaffolds for Building Gastrointestinal Tissue. Cell Mol Gastroenterol Hepatol, 5, 1–13.
Wang, S., Gao, D., & Chen, Y. (2017). The potential of organoids in urological cancer research. Nat Rev Urol, 14, 401–414.
Stoltz, J. F., Zhang, L., Ye, J. S., & De Isla, N. (2017). Organ reconstruction: Dream or reality for the future. Biomed Mater Eng, 28, S121–S1s7.
Rana, D., Zreiqat, H., Benkirane-Jessel, N., Ramakrishna, S., & Ramalingam, M. (2017). Development of decellularized scaffolds for stem cell-driven tissue engineering. J Tissue Eng Regen Med, 11, 942–965.
Peloso, A., Dhal, A., Zambon, J. P., et al. (2015). Current achievements and future perspectives in whole-organ bioengineering. Stem Cell Res Ther, 6, 107.
Baldwin, T. (2009). Morality and human embryo research. Introduction to the Talking Point on morality and human embryo research. EMBO Rep, 10, 299–300.
Langlois, A. (2017). The global governance of human cloning: the case of UNESCO. Palgrave Commun, 3, 17019.
Hongisto, H., Vuoristo, S., Mikhailova, A., et al. (2012). Laminin-511 expression is associated with the functionality of feeder cells in human embryonic stem cell culture. Stem Cell Res, 8, 97–108.
Villa-Diaz, L. G., Pacut, C., Slawny, N. A., Ding, J., O'Shea, K. S., & Smith, G. D. (2009). Analysis of the factors that limit the ability of feeder cells to maintain the undifferentiated state of human embryonic stem cells. Stem Cells Dev, 18, 641–651.
Llames, S., Garcia-Perez, E., Meana, A., Larcher, F., & del Rio, M. (2015). Feeder Layer Cell Actions and Applications. Tissue Eng Part B Rev, 21, 345–353.
Jung JH, Kim BS. A Novel Culture Model for Human Pluripotent Stem Cell Propagation on Gelatin in Placenta-conditioned Media. J Vis Exp 2015:e53204.
Villa-Diaz, L. G., Nandivada, H., Ding, J., et al. (2010). Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol, 28, 581–583.
Villa-Diaz, L. G., Ross, A. M., Lahann, J., & Krebsbach, P. H. (2013). Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells, 31, 1–7.
Takenaka, C., Miyajima, H., Yoda, Y., et al. (2015). Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS One, 10, e0129855.